Show simple item record

AuthorXu, Chang
AuthorKwong, Joey S. W.
AuthorJia, Pengli
AuthorLiu, Yu
AuthorZhang, Weixin
AuthorQin, Zongshi
AuthorLiu, Tongzu
Available date2023-09-06T05:27:57Z
Publication Date2021
Publication NameJournal of Evidence-Based Medicine
ResourceScopus
ISSN17565383
URIhttp://dx.doi.org/10.1111/jebm.12446
URIhttp://hdl.handle.net/10576/47253
AbstractMeta-analysis is an important tool for summarizing findings from scientific research. But for harm outcomes,issues may arise due to the distribution problems, zero-events problems, as well as low statistical power. Individual participant data (IPD) meta-analysis represents a viable approach to overcome these shortcomings because all eligible small-scale studies can be treated as one large trial with multiple clusters through a one-stage analytic. An increasing number of IPD meta-analyses of healthcare interventions are published over the past years.6 Findings from these IPD meta-analyses contribute to the evolving body of best available evidence for informed decision-making. However, quality of safety reporting by the emerging IPD meta-analyses remains to be ascertained. In this study, we appraised the reporting of IPD meta-analyses, with a special focus on safety outcomes.
SponsorL.TZ is funded by a National Key Research and Development Plan of China (Grant No. 2016YFC0106300).
Languageen
PublisherJohn Wiley and Sons Inc
Subjectdata quality
decision making
financial management
human
information
Letter
meta analysis
systematic review
Humans
Systematic Reviews as Topic
TitleInformation on harm outcomes was insufficiently reported in systematic reviews and meta-analyses of individual participant data
TypeOther
Pagination265-268
Issue Number4
Volume Number14
dc.accessType Abstract Only


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record